Cargando…
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
The outbreak of coronavirus disease 2019 (COVID-19) has put health systems worldwide under great pressure on numerous levels. COVID-19 is a heterogeneous situation where some people experience mild symptoms for which no serious intervention is needed, while others may experience serious situations r...
Autores principales: | Salamoon, Maher, Kenj, Mazen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204116/ https://www.ncbi.nlm.nih.gov/pubmed/34149939 http://dx.doi.org/10.1007/s12254-021-00719-z |
Ejemplares similares
-
Hemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibition
por: Guild, Allison, et al.
Publicado: (2022) -
A Case of Human Immunodeficiency Virus-triggered Hemophagocytic Lymphohistocytosis Presenting with Severe Bleeding Tendency
por: Kim, Bongyoung, et al.
Publicado: (2021) -
PB1942: HEPATIC MANIFESTATIONS OF CHILDHOOD HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS
por: El Sayed, M., et al.
Publicado: (2022) -
Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters
por: Amir, Rawan, et al.
Publicado: (2020) -
Risk factors of early death in pediatric hemophagocytic lymphohistocytosis: Retrospective cohort study
por: Zhang, Lijun, et al.
Publicado: (2022)